SCHEMBL21837255

SCHEMBL21837255

CCCC(=O)C1CCN([C@H]2CCCN(C(=O)O)CC2)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.45
L3MBTL3 Q96JM7 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
TP53 P04637 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CHRM2 P08172 2/20 0.37
CHRM3 P20309 1/20 0.37
MBTD1 Q05BQ5 1/20 0.36
CHRM4 P08173 1/20 0.36
ABL1 P00519 1/20 0.36
RIN1 Q13671 1/20 0.36
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21837269 0.89 CHRM1 (0.46) CHRM1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL21837261 0.85 CHRM1 (0.64) CHRM1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL31348822 0.85 ABL1 (0.44) SMN1; SMN2POLBABL1RIN1ALDH1A1
SCHEMBL21837270 0.81 CHRM1 (0.42) CHRM1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL18825283 0.81 CHRM1 (0.42) CHRM1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL18825281 0.81 CHRM1 (0.42) CHRM1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL21837271 0.81 CHRM1 (0.42) CHRM1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL18825113 0.81 L3MBTL3 (0.45) CHRM1L3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL28037969 0.80 CHRM1 (0.56) CHRM1MEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL16210548 0.77 SMN1; SMN2 (0.51) CHRM1L3MBTL3L3MBTL1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3797778-A1 OXIME COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR Heptares Therapeutics Limited (GB) 2021-03-31 EP disclosed
EP-3370828-B1 OXIME COMPOUNDS AS AGONISTS OF THE MUSCARINIC M1 AND/OR M4 RECEPTOR HEPTARES THERAPEUTICS LTD (GB) 2020-04-15 EP disclosed